Receive Windhover's unique market insight fast with our free alert
service 'Windhover's Update', including the latest abstracts
and summaries from:
• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight
Sign up
now
|
|
|
Receive Windhover's Unique Market Insight Fast with 'Windhover's Update': Our Free E-mail Alert Service
|
|
 |
|
 |
|
|
| |
 |
Pfizer's Ambitions in the Off-Patent World
The pending purchase of Wyeth will accelerate Pfizer's transformation from a mass marketer of superstar drugs into a . . .[MORE
. . .] (IN VIVO)
The Epigenetics (R)evolution
Constellation and EpiZyme are poised to become dominant players in the unfolding field of epigenetics, an area of biology . . . [MORE. . .] (Start-Up)
A New Era Dawns in Physician-Device Industry Relationships
The push for transparency in the health care industry has moved beyond initial regulations focused on hospital safety . . .[MORE. . .] (Medtech Insight)
The Cost-Sharing Solution: The New NICE Ticket
J&J's Velcade and Celgene's Revlimid illustrate how pharma has adapted to the NICE UK cost-effectiveness watchdog. Now that . . .[MORE. . .] (The RPM Report)
Read
more from the latest:
IN VIVO,
Start-Up,
The RPM Report,
Medtech Insight, "The Pink Sheet",
"The Pink Sheet" DAILY,
"The Rose Sheet",
"The Tan Sheet",
PharmAsia News,
Pharmaceutical Approvals Monthly, and
"The Gray Sheet".
|
|
|
|
| |
|
|
|
